BioCentury
ARTICLE | Company News

OrthoMimetics, TiGenix deal

December 7, 2009 8:00 AM UTC

TiGenix completed its previously announced acquisition of OrthoMimetics in a stock deal valued at €16 million ($24 million). The price includes 3.01 million new TiGenix shares valued at €12.6 million ...